INTELLIA THERAPEUTICS INC

NTLA · NASDAQ

Updated at 2026-11-16 20:46:21

$9.82+1.23%
Today's High
$10.47
Today’s Low
$9.70
INTELLIA THERAPEUTICS INC (NTLA) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$10.45
Previous Close
$9.70
Volume
11.41M
Market Cap
$1.36B
P/E Ratio
--
EPS
$-3.35

Previous Day Range

$9.66$10.50

52-Week Range

$7.95$18.48

Company Overview

Sector
HEALTHCARE
Industry
Biotechnology
Sub-industry
BIOTECHNOLOGY
Headquarters
400 TECHNOLOGY SQUARE, CAMBRIDGE, MA, UNITED STATES, 02139
Country
US
Listing Date
2016-05-06
Fiscal Year End
December
Shares Outstanding
140.13M
CIK
0001652130

Intellia Therapeutics, Inc., a genome editing company, is focused on developing therapies. The company is headquartered in Cambridge, Massachusetts.

Financial Metrics

Revenue

2026-09-30

$7.16M

2026-06-30

$7.65M

2026-03-31

$15.04M

2025-12-31

$23.01M

Operating Expenses

2026-09-30

$129.48M

2026-06-30

$120.41M

2026-03-31

$113.37M

2025-12-31

$115.71M

Net Income

2026-09-30

-$127.48M

2026-06-30

-$106.63M

2026-03-31

-$96.23M

2025-12-31

-$95.78M

Net Profit Margin

2026-09-30

-1.77K%

2026-06-30

-1.39K%

2026-03-31

-639.49%

2025-12-31

-416.15%

Earnings Per Share

2026-09-30

$-0.91

2026-06-30

$-0.80

2026-03-31

$-0.81

2025-12-31

$-0.83

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-09-30

-$126.87M

2026-06-30

-$104.55M

2026-03-31

-$94.02M

2025-12-31

-$95.4M

Effective Tax Rate

2026-09-30

--

2026-06-30

--

2026-03-31

--

2025-12-31

--

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.